| Interval-censored time-to-event and competing risk with death: is the illness-death model more accurate than the Cox model? K Leffondré, C Touraine, C Helmer, P Joly International journal of epidemiology 42 (4), 1177-1186, 2013 | 83 | 2013 |
| Gait speed and decline in gait speed as predictors of incident dementia J Dumurgier, F Artaud, C Touraine, O Rouaud, B Tavernier, C Dufouil, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017 | 77 | 2017 |
| Predictions in an illness-death model C Touraine, C Helmer, P Joly Statistical methods in medical research 25 (4), 1452-1470, 2016 | 49 | 2016 |
| The SmoothHazard package for R: Fitting regression models to interval-censored observations of illness-death models C Touraine, TA Gerds, P Joly Journal of Statistical Software 79 (7), 2017 | 35* | 2017 |
| Distribution-and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review A Ousmen, C Touraine, N Deliu, F Cottone, F Bonnetain, F Efficace, ... Health and quality of life outcomes 16 (1), 1-12, 2018 | 22 | 2018 |
| Prevalence projections of chronic diseases and impact of public health intervention P Joly, C Touraine, A Georget, JF Dartigues, D Commenges, ... Biometrics 69 (1), 109-117, 2013 | 20 | 2013 |
| Receiver operating characteristic curve estimation for time to event with semicompeting risks and interval censoring H Jacqmin-Gadda, P Blanche, E Chary, C Touraine, JF Dartigues Statistical methods in medical research 25 (6), 2750-2766, 2016 | 10 | 2016 |
| Modèles illness-death pour données censurées par intervalle: application à l'étude de la démence C Touraine Bordeaux 2, 2013 | 8 | 2013 |
| ADL disability and death in dementia in a French population-based cohort: new insights with an illness-death model F Delva, C Touraine, P Joly, A Edjolo, H Amieva, C Berr, O Rouaud, ... Alzheimer's & Dementia 12 (8), 909-916, 2016 | 7 | 2016 |
| SmoothHazard: Fitting illness-death model for interval-censored data C Touraine, P Joly, TA Gerds R package version 1.2 3, 2014 | 6 | 2014 |
| Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review E Charton, B Cuer, F Cottone, F Efficace, C Touraine, Z Hamidou, F Fiteni, ... Quality of Life Research 29 (4), 867-878, 2020 | 4 | 2020 |
| More accurate cancer-related excess mortality through correcting background mortality for extra variables C Touraine, N Grafféo, R Giorgi, CENSUR working survival group Statistical methods in medical research 29 (1), 122-136, 2020 | 4 | 2020 |
| A new score to predict the resectability of pancreatic adenocarcinoma: the BACAP score C Maulat, C Canivet, C Touraine, S Gourgou, B Napoleon, L Palazzo, ... Cancers 12 (4), 783, 2020 | 3 | 2020 |
| Kinetics of HE4 and CA125 markers in metastatic ovarian cancer: The META4 study. PJ Lamy, C Touraine, C Mollevi, S Roques, C Viglianti, F Montels, ... Journal of Clinical Oncology 35 (15_suppl), e17059-e17059, 2017 | 2 | 2017 |
| Impact d’un programme d’activité physique et de conseil diététique sur la qualité de vie relative à la santé de femmes atteintes de cancer du sein non métastatique sous … C Touraine, W Jacot, S Gourgou, M Carayol, G Ninot, P Senesse, ... Revue d’Épidémiologie et de Santé Publique 66, S174, 2018 | 1 | 2018 |
| Méthodes de détermination de la différence minimale cliniquement importante pour les questionnaires de qualité de vie relative à la santé en cancérologie A Anota, C Touraine, A Ousmen, N Deliu, F Efficace, F Bonnetain, ... Revue d'Épidémiologie et de Santé Publique 65, S66, 2017 | 1 | 2017 |
| Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results C Bascoul-Mollevi, A Barbieri, C Bourgier, T Conroy, B Chauffert, ... Quality of Life Research 30 (1), 91-103, 2021 | | 2021 |
| Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial … B Cuer, C Mollevi, A Anota, E Charton, B Juzyna, T Conroy, C Touraine BMC medical research methodology 20 (1), 1-13, 2020 | | 2020 |
| GUIP1: a R package for dose escalation strategies in phase I cancer clinical trials D Dinart, J Fraisse, D Tosi, A Mauguen, C Touraine, S Gourgou, ... BMC medical informatics and decision making 20 (1), 1-9, 2020 | | 2020 |
| Modèle conjoint versus modèle linéaire mixte pour l’analyse de données de qualité de vie dont le recueil est interrompu par la survenue d’un évènement clinique en oncologie C Touraine, B Cuer, T Conroy, B Juzyna, S Gourgou, C Mollevi Revue d'Épidémiologie et de Santé Publique 68, S131, 2020 | | 2020 |
Thomas Alexander GerdsProfessor of biostatistics, University of CopenhagenBekræftet mail på biostat.ku.dk
